Tejara Capital LTD Precision Biosciences Inc Transaction History

Tejara Capital LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$0.29 - $0.45 $99,876 - $154,980	344,400 Added 86.4%	743,014 $271 Million
Q3 2023 Nov 13, 2023	BUY	$0.34 - $0.69 $68,000 - $138,000	200,000 Added 100.7%	398,614 $136 Million
Q2 2023 Aug 11, 2023	SELL	$0.52 - $0.91 $5,764 - $10,088	-11,086 Reduced 5.29%	198,614 $104 Million
Q1 2023 May 12, 2023	SELL	$0.7 - $1.41 $35,000 - $70,500	-50,000 Reduced 19.25%	209,700 $158 Million
Q4 2022 Feb 13, 2023	BUY	$0.97 - $45.0 $251,909 - $11.7 Million	259,700 New	259,700 $309 Million

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $550M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Tejara Capital LTD with notifications on news.